Drug Shortage Report for LEVOTHYROXINE SODIUM FOR INJECTION

Last updated on 2020-11-16 History
Report ID 127630
Drug Identification Number 02461722
Brand name LEVOTHYROXINE SODIUM FOR INJECTION
Common or Proper name Levothyroxine 500mcg / vial
Company Name AVIR PHARMA INC.
Market Status MARKETED
Active Ingredient(s) LEVOTHYROXINE SODIUM
Strength(s) 500MCG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1
ATC code H03AA
ATC description THYROID PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-10-30
Actual start date 2020-10-31
Estimated end date 2020-11-13
Actual end date 2020-11-09
Shortage status Resolved
Updated date 2020-11-16
Company comments Levothyroxine 200mcg/vial available
Health Canada comments
Tier 3 Status No
Contact Address 660 BOULEVARD INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-11-16 French Compare
v7 2020-11-16 English Compare
v6 2020-11-01 English Compare
v5 2020-10-30 French Compare
v4 2020-10-30 English Compare
v3 2020-10-30 French Compare
v2 2020-10-30 English Compare
v1 2020-10-30 English Compare

Showing 1 to 8 of 8